Dorman Products (DORM) | Financial Analysis & Statements
Dorman Products Inc. Mid-cap Consumer Cyclical
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Latest Quarterly: Dec 2025Income Metrics
Revenue
537.9M
Gross Profit
229.1M
42.59%
Operating Income
87.9M
16.35%
Net Income
11.6M
2.15%
EPS (Diluted)
$0.38
Balance Sheet Metrics
Total Assets
2.5B
Total Liabilities
1.0B
Shareholders Equity
1.5B
Debt to Equity
0.69
Cash Flow Metrics
Operating Cash Flow
-26.0M
Free Cash Flow
33.5M
Revenue & Profitability Trend
Quarter Income Flow
Dec 31, 2025
Annual Income Flow
2025
Dorman Products Income Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 2.1B | 2.0B | 1.9B | 1.7B | 1.3B |
| Cost of Goods Sold | 1.2B | 1.2B | 1.2B | 1.2B | 882.3M |
| Gross Profit | 897.7M | 806.4M | 685.4M | 564.4M | 462.9M |
| Gross Margin % | 42.1% | 40.1% | 35.5% | 32.6% | 34.4% |
| Operating Expenses | |||||
| Research & Development | - | - | - | - | - |
| Selling, General & Administrative | 541.5M | 513.4M | 470.7M | 393.4M | 291.4M |
| Other Operating Expenses | - | - | - | - | - |
| Total Operating Expenses | 541.5M | 513.4M | 470.7M | 393.4M | 291.4M |
| Operating Income | 356.3M | 292.9M | 214.8M | 171.0M | 171.6M |
| Operating Margin % | 16.7% | 14.6% | 11.1% | 9.9% | 12.8% |
| Non-Operating Items | |||||
| Interest Income | - | - | - | - | - |
| Interest Expense | 28.6M | 39.7M | 48.1M | 15.6M | 2.2M |
| Other Non-Operating Income | -52.2M | 3.1M | 1.8M | 735.0K | 377.0K |
| Pre-tax Income | 275.4M | 256.3M | 168.5M | 156.2M | 169.8M |
| Income Tax | 71.3M | 66.2M | 39.2M | 34.7M | 38.2M |
| Effective Tax Rate % | 25.9% | 25.9% | 23.3% | 22.2% | 22.5% |
| Net Income | 204.2M | 190.0M | 129.3M | 121.5M | 131.5M |
| Net Margin % | 9.6% | 9.5% | 6.7% | 7.0% | 9.8% |
| Key Metrics | |||||
| EBITDA | 416.5M | 352.7M | 271.3M | 216.5M | 207.1M |
| EPS (Basic) | $6.69 | $6.22 | $4.13 | $3.87 | $4.16 |
| EPS (Diluted) | $6.64 | $6.14 | $4.10 | $3.85 | $4.12 |
| Basic Shares Outstanding | 30541000 | 30565855 | 31299770 | 31430632 | 31607509 |
| Diluted Shares Outstanding | 30541000 | 30565855 | 31299770 | 31430632 | 31607509 |
Income Statement Trend
Join Our United States Telegram Channel
Get Instant Market Updates: 52-Week High/Low Alerts, Breakout Notifications & Expert Stock Analysis Delivered To Your Phone. Join Traders Making Informed Decisions Daily!
Dorman Products Balance Sheet From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Assets | |||||
| Current Assets | |||||
| Cash & Equivalents | 49.4M | 57.1M | 36.8M | 46.0M | 58.8M |
| Short-term Investments | - | - | - | - | - |
| Accounts Receivable | 479.3M | 573.8M | 526.9M | 427.4M | 472.8M |
| Inventory | 959.0M | 708.0M | 637.4M | 755.9M | 532.0M |
| Other Current Assets | 33.8M | 30.9M | 32.7M | 39.8M | 13.0M |
| Total Current Assets | 1.5B | 1.4B | 1.2B | 1.3B | 1.1B |
| Non-Current Assets | |||||
| Property, Plant & Equipment | 112.8M | 118.5M | 103.5M | 110.0M | 59.0M |
| Goodwill | 1.0B | 1.2B | 1.2B | 1.2B | 573.5M |
| Intangible Assets | 257.1M | 278.2M | 301.6M | 322.4M | 178.8M |
| Long-term Investments | - | - | - | - | - |
| Other Non-Current Assets | 45.6M | 50.7M | 49.7M | 48.8M | 46.5M |
| Total Non-Current Assets | 971.6M | 1.1B | 1.1B | 1.1B | 596.5M |
| Total Assets | 2.5B | 2.4B | 2.3B | 2.3B | 1.7B |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts Payable | 185.1M | 231.8M | 176.7M | 179.8M | 177.4M |
| Short-term Debt | 37.5M | 42.1M | 108.4M | 251.9M | 239.4M |
| Current Portion of Long-term Debt | - | - | - | - | - |
| Other Current Liabilities | - | - | - | - | - |
| Total Current Liabilities | 492.8M | 563.8M | 547.2M | 678.3M | 665.0M |
| Non-Current Liabilities | |||||
| Long-term Debt | 499.0M | 544.7M | 558.5M | 580.7M | 52.4M |
| Deferred Tax Liabilities | 4.0M | 3.7M | 8.9M | 11.8M | 18.0M |
| Other Non-Current Liabilities | 20.2M | 18.9M | 9.6M | 28.3M | 4.9M |
| Total Non-Current Liabilities | 523.2M | 567.2M | 577.1M | 620.9M | 75.3M |
| Total Liabilities | 1.0B | 1.1B | 1.1B | 1.3B | 740.4M |
| Equity | |||||
| Common Stock | 304.0K | 306.0K | 313.0K | 314.0K | 316.0K |
| Retained Earnings | 1.3B | 1.2B | 1.1B | 956.9M | 856.4M |
| Treasury Stock | - | - | - | - | - |
| Other Equity | - | - | - | - | - |
| Total Shareholders Equity | 1.5B | 1.3B | 1.2B | 1.0B | 932.7M |
| Key Metrics | |||||
| Total Debt | 536.5M | 586.7M | 666.9M | 832.5M | 291.8M |
| Working Capital | 1.0B | 806.0M | 686.6M | 590.8M | 411.5M |
Balance Sheet Composition
Dorman Products Cash Flow Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | 204.2M | 190.0M | 129.3M | 121.5M | 131.5M |
| Depreciation & Amortization | 55.7M | 56.7M | 54.7M | 44.7M | 35.2M |
| Stock-Based Compensation | 19.6M | 15.0M | 11.5M | 9.4M | 8.2M |
| Working Capital Changes | -218.9M | -14.9M | 4.4M | -119.3M | -89.0M |
| Operating Cash Flow | 66.9M | 235.9M | 196.9M | 50.3M | 71.6M |
| Investing Activities | |||||
| Capital Expenditures | -38.0M | -39.4M | -44.0M | -37.9M | -19.8M |
| Acquisitions | 0 | 100.0K | 67.0K | -489.0M | -345.5M |
| Investment Purchases | - | - | - | - | - |
| Investment Sales | - | - | - | - | - |
| Investing Cash Flow | -38.0M | -39.3M | -43.9M | -526.8M | -365.3M |
| Financing Activities | |||||
| Share Repurchases | -40.6M | -80.8M | -15.7M | -19.9M | -62.6M |
| Dividends Paid | - | - | - | - | - |
| Debt Issuance | - | 0 | 0 | 500.0M | 0 |
| Debt Repayment | -42.1M | -94.4M | -159.1M | -13.1M | -13.0M |
| Financing Cash Flow | -101.3M | -254.5M | -321.9M | 461.4M | 152.8M |
| Free Cash Flow | 75.7M | 191.6M | 164.8M | 3.8M | 80.5M |
| Net Change in Cash | -72.5M | -57.9M | -168.8M | -15.1M | -141.0M |
Cash Flow Trend
Dorman Products Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
16.69
Forward P/E
11.96
Price to Book
2.28
Price to Sales
1.57
PEG Ratio
-0.21
Profitability Ratios
Profit Margin
9.59%
Operating Margin
8.22%
Return on Equity
14.74%
Return on Assets
9.06%
Financial Health
Current Ratio
3.09
Debt to Equity
37.98
Beta
0.96
Per Share Data
EPS (TTM)
$6.64
Book Value per Share
$48.60
Revenue per Share
$69.75
Peer Financial Comparison
| Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
|---|---|---|---|---|---|---|
| DORM | 3.3B | 16.69 | 2.28 | 14.74% | 9.59% | 37.98 |
| O'Reilly Automotive | 78.2B | 31.59 | -103.12 | -332.51% | 14.27% | -11.12 |
| AutoZone | 59.6B | 25.25 | -20.51 | -73.17% | 12.47% | -4.42 |
| Autoliv | 8.7B | 12.67 | 3.34 | 28.37% | 6.45% | 85.17 |
| LKQ | 8.0B | 13.53 | 1.22 | 9.48% | 4.45% | 77.14 |
| Mobileye Global | 6.6B | - | 0.54 | -3.27% | -20.70% | 0.52 |
Financial data is updated regularly. All figures are in the company's reporting currency.






